Omeros reported $4.91M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 614K 58K
Adma Biologics ADMA:US $ 3.25M 0.05M
Aerie Pharmaceuticals AERI:US $ 7.12M 0.22M
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Alnylam Pharmaceuticals ALNY:US $ 33.42M 901K
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Cytokinetics CYTK:US $ 4.07M 0.08M
Dynavax Technologies DVAX:US $ 3.11M 1.6M
Gilead Sciences GILD:US $ 256M 1M
Insmed INSM:US $ 10.32M 2.76M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
Knight Therapeutics Inc GUD:CN C$ 668K 8K
Omeros OMER:US $ 4.91M 13K
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Pfizer PFE:US $ 316M 20M
Rockwell Medical RMTI:US $ 0.58M 0M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
United Therapeutics UTHR:US $ 4.7M 0.1M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
Xoma XOMA:US $ 172K 117K